Source:http://linkedlifedata.com/resource/pubmed/id/20890426
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
10
|
| pubmed:dateCreated |
2010-10-4
|
| pubmed:abstractText |
We sought to determine the prevalence of metabolic syndrome (MS) in patients with acute myocardial infarction and its effect on clinical outcomes. Employing data from the Korea Acute Myocardial Infarction Registry, a total of 1,990 patients suffered from acute ST-elevation myocardial infarction (STEMI) between November 2005 and December 2006 were categorized according to the National Cholesterol Education Program-Adult Treatment Panel III criteria of MS. Primary study outcomes included major adverse cardiac events (MACE) during one-year follow-up. Patients were grouped based on existence of MS: group I: MS (n=1,182, 777 men, 62.8±12.3 yr); group II: Non-MS (n=808, 675 men, 64.2±13.1 yr). Group I showed lower left ventricular ejection fraction (LVEF) (P=0.005). There were no differences between two groups in the coronary angiographic findings except for multivessel involvement (P=0.01). The incidence of in-hospital death was higher in group I than in group II (P=0.047), but the rates of composite MACE during one-year clinical follow-up showed no significant differences. Multivariate analysis showed that low LVEF, old age, MS, low high density lipoprotein cholesterol and multivessel involvement were associated with high in-hospital death rate. In conclusion, MS is an important predictor for in-hospital death in patients with STEMI.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
1598-6357
|
| pubmed:author |
pubmed-author:AhnYoungkeunY,
pubmed-author:BaeJang HoJH,
pubmed-author:ChaeIn HoIH,
pubmed-author:ChaeJei KeonJK,
pubmed-author:ChaeShung ChullSC,
pubmed-author:ChoJeong GwanJG,
pubmed-author:ChoMyeong ChanMC,
pubmed-author:ChoiDonghoonD,
pubmed-author:ChungWook SungWS,
pubmed-author:HongTaek JongTJ,
pubmed-author:HurSeung HoSH,
pubmed-author:JangYang SooYS,
pubmed-author:JeongMyung HoMH,
pubmed-author:KimChong JinCJ,
pubmed-author:KimYoung JoYJ,
pubmed-author:LeeMin GooMG,
pubmed-author:ParkSeung JungSJ,
pubmed-author:RhaSeung WoonSW,
pubmed-author:RhewJay YoungJY,
pubmed-author:SeongIn WhanIW,
pubmed-author:SeungKi BaeKB,
pubmed-author:YoonJunghanJ
|
| pubmed:issnType |
Electronic
|
| pubmed:volume |
25
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1456-61
|
| pubmed:meshHeading |
pubmed-meshheading:20890426-Acute Disease,
pubmed-meshheading:20890426-Age Factors,
pubmed-meshheading:20890426-Aged,
pubmed-meshheading:20890426-C-Reactive Protein,
pubmed-meshheading:20890426-Cholesterol, LDL,
pubmed-meshheading:20890426-Coronary Angiography,
pubmed-meshheading:20890426-Female,
pubmed-meshheading:20890426-Humans,
pubmed-meshheading:20890426-Male,
pubmed-meshheading:20890426-Metabolic Syndrome X,
pubmed-meshheading:20890426-Middle Aged,
pubmed-meshheading:20890426-Multivariate Analysis,
pubmed-meshheading:20890426-Myocardial Infarction,
pubmed-meshheading:20890426-Predictive Value of Tests,
pubmed-meshheading:20890426-Prognosis,
pubmed-meshheading:20890426-Treatment Outcome,
pubmed-meshheading:20890426-Ventricular Dysfunction, Left
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Impact of the metabolic syndrome on the clinical outcome of patients with acute ST-elevation myocardial infarction.
|
| pubmed:affiliation |
The Heart Center of Chonnam National University Hospital, Gwangju, Korea.
|
| pubmed:publicationType |
Journal Article
|